Sign inJoin waitlistJoin the waitlist

Nasheed Hossain

Co-Director · University of Pennsylvania Health System

Credentials: · · · ·

History

University of Pennsylvania Health System
Present
University of Pennsylvania Health System
Present
Perelman School of Medicine at the University of Pennsylvania
Present

Stanford University Medical Center
2014–2015
Fox Chase Cancer Center
2013–2014
Stanford University School of Medicine
Internal Medicine
University of Chicago Medical Center
2010–2013
Case Western Reserve University School of Medicine
2006–2010
Cornell University
2002–2006

Research

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Nature Medicine · 2021 · 534 citations
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional…
Journal of Clinical Oncology · 2021 · 141 citations
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
Blood Advances · 2019 · 106 citations

Mohamed Dabaja
13 papers
BS
Bipin Savani
12 papers
Hillard Lazarus
12 papers
SH
Shahrukh Hashmi
12 papers
TN
Taiga Nishihori
12 papers
Hemant Murthy
10 papers
JC
Jan Cerny
9 papers · 8 as a resident
Jean Yared
9 papers
NF
Nosha Farhadfar
9 papers · 4 as a fellow
Wael Saber
9 papers
BW
Baldeep Wirk
8 papers
Mark Litzow
8 papers

Clinical trials

CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies
Principal investigator · Active not recruiting · Phase 1
Loyola University
2019–2034
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2023–2030